Trade Summary

4 months ago, Andrews Patricia S, serving as Dir at Oncolytics Biotech Inc (ONCY), purchased 35,400 shares at $0.86 per share, for a total transaction value of $30,292.00. Following this transaction, Andrews Patricia S now holds 78,128 shares of ONCY.

This purchase represents a 83.00% increase in Andrews Patricia S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, February 12, 2026 and publicly disclosed via SEC Form 4 filing on Friday, February 13, 2026 at 7:00 AM ET, 1 day after the trade was made.

Oncolytics Biotech Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.